|
Home:
Recent
Publications: Recent
Publications 2000
Low-dose
oral fluorouracil with eniluracil as first-line chemotherapy against
advanced breast cancer: A phase II study.
Smith,
I. E.; Johnston, S. R. D.; O'Brien, M. E. R.; Hickish, T. F.; de
Boer, R. H.; Norton, A.; Cirkel, D. T., and Barton, C. M.. Journal
of Clinical Oncology. 18(12):2378-2384, 2000 Jun.
Comparison
of chemotherapy with chemohormonal therapy as first-line therapy-for
metastatic, hormone-sensitive breast cancer: An Eastern Cooperative
Oncology Group study.
Sledge,
G. W.; Hu, P.; Falkson, G.; Tormey, D., and Abeloff, M.. Journal
of Clinical Oncology. 18(2):262-266, 2000 Jan.
Assessment
of the need for palliative care as perceived by individual cancer
patients and their families - A review of instruments for improving
patient participation in palliative care [Review].
Osse,
B. H. P.; Vernooij-Dassen MJFJ; de Vree, B. P. W.; Schade, E.,
and Grol RPTM. Cancer. 88(4):900-911, 2000 Feb 15.
Anastrozole
is superior to tamoxifen as first-line therapy for advanced breast
cancer in postmenopausal women: Results of a North American multicenter
randomized trial.
Nabholtz,
J. M.; Buzdar, A.; Pollak, M.; Harwin, W.; Burton, G.; Mangalik,
A.; Steinberg, M.; Webster, A., and von Euler, M. Journal of Clinical
Oncology. 18(22):3758-3767, 2000 Nov 15.
Single
agent epirubicin as first line chemotherapy for metastatic breast
cancer patients.
Michelotti,
A.; Venturini, M.; Tibaldi, C.; Bengala, C.; Gallo, L.; Carnino,
F.; Del Mastro, L.; Lionetto, R.; Montanaro, E.; Rosso, R., and
Conte, P. (Reprint available from: Conte P Osped S Chiara, Dipartimento
Oncol, UO Oncol Med Via Roma 67 I-56100 Pisa Italy). Breast Cancer
Research & Treatment. 59(2):133-139, 2000 Jan.
Pamidronate
prevents skeletal complications and is effective palliative treatment
in women with breast carcinoma and osteolytic bone metastases -
Long term follow-up of two randomized, placebo controlled trials.
Lipton,
A.; Theriault, R. L.; Hortobagyi, G. N.; Simeone, J.; Knight, R.
D.; Mellars, K.; Reitsma, D. J.; Heffernan, M., and Seaman, J. J..
Cancer. 88(5):1082-1090, 2000 Mar 1.
Prognostic
significance of an increased number of micrometastatic tumor cells
in the bone marrow of patients with first recurrence of breast carcinoma.
Janni,
W.; Gastroph, S.; Hepp, F.; Kentenich, C.; Rjosk, D.; Schindlbeck,
C.; Dimpfl, T.; Sommer, H., and Braun, S.. Cancer. 88(10):2252-2259,
2000 May 15.
Pamidronate
in prevention of bone complications in metastatic breast cancer:
A cost-effectiveness analysis.
Hillner,
B. E.; Weeks, J. C.; Desch, C. E., and Smith, T. J.. Journal of
Clinical Oncology. 18(1):72-79, 2000 Jan.
Phase
III trial of cyclophosphamide, epirubicin, fluorouracil (CEF) versus
cyclophosphamide, mitoxantrone, fluorouracil (CNF) in women with
metastatic breast cancer.
Esteban,
E.; Lacave, A. J.; Fernandez, J. L.; Corral, N.; Buesa, J. M.; Estrada,
E.; Palacio, I.; Vieitez, J. M.; Muniz, I., and Alvarez, E. Breast
Cancer Research & Treatment. 58(2):141-150, 1999 Nov.
A
phase II trial of cyclophosphamide, epirubicin and vinorelbine in
the treatment of advanced breast cancer Esteban, E.; de Sande,
G.; Puertas, J.; Fra, J.; Palacio, I.;
Vieitez,
J. M.; Fernandez, J. L.; Muniz, I.; Modollel, A.; Carrasco, J.;
Sala, M., and Lacave, A. J.. Breast Cancer Research & Treatment.
62(2):127-133, 2000 Jul.
Predictors
of skeletal complications in patients with metastatic breast carcinoma.
Domchek,
S. M.; Younger, J.; Finkelstein, D. M., and Seiden, M. V. Cancer.
89(2):363-368, 2000 Jul 15.
Vinorelbine
plus mitomycin C as second-line treatment of metastatic breast cancer:
A two-stage phase 2 study
De
Placido, S.; Lauria, R.; Perrone, F.; Lombardi, A. V.; Carlomagno,
C.; Varriale, E.; Costanzo, R.; Leo, L.; De Laurentiis, M., and
Bianco, A. R. (Reprint available from: De Placido S Univ Naples
Federico II, Cattedra Oncol Med Via S Pansini 5 I-80131 Naples Italy)..
Oncology. 58(1):8-14, 2000.
Paclitaxel/gemcitabine
administered every two weeks in advanced breast cancer: Preliminary
results of a phase II trial [Review].
Colomer,
R.; Llombart, A.; Lluch, A.; Ojeda, B.; Barnadas, A.; Caranana,
V.; Fernandez, Y.; De Paz, L.; Guillem, V., and Alonso, S. Seminars
in Oncology. 27(1 Suppl 2):20-24, 2000 Feb.
Vinorelbine
combined with paclitaxel infused over 96 hours (VI-TA-96) for patients
with metastatic breast carcinoma.
Cocconi,
G.; Mambrini, A.; Quarta, M.; Vasini, G.; Bella, M. A.; Ferrozzi,
F., and Beretta, M. D.. Cancer. 88(12):2731-2738, 2000 Jun 15.
Quality-of-life
scores predict outcome in metastatic but not early breast cancer.
Coates,
A. S.; Hurny, C.; Peterson, H. F.; Bernhard, J.; Castiglione-Gertsch,
M.; Gelber, R. D., and Goldhirsch, A. Journal of Clinical Oncology.
18(22):3768-3774, 2000 Nov 15.
Docetaxel
administered on a weekly basis for metastatic breast cancer.
Burstein,
H. J.; Manola, J.; Younger, J.; Parker, L. M.; Bunnell, C. A.; Scheib,
R.; Matulonis, U. A.; Garber, J. E.; Clarke, K. D.; Shulman, L.
N., and Winer, E. P.. Journal of Clinical Oncology. 18(6):1212-1219,
2000 Mar.
Epirubicin-based
chemotherapy in metastatic breast cancer patients: Role of dose-intensity
and duration of treatment.
Bastit,
P.; Chevallier, B.; Chevreau, C.; Mihura, J.; Roche, H.; Namer,
M.; Gedouin, D.; Kerbrat, P.; Lesimple, T.; Coudert, B.; Fargeot,
P.; de Gislain, C.; Mayer, F.; Luporsi, E.; Rios, M.; Weber, B.;
Bremond, A.; Devaux, Y.; Monteuquet, P.; Schraub, S.; Hayat, M.;
Zambon, E.; Grandgirard, A.; Monnier, A.; Sun, X. and others. Journal
of Clinical Oncology. 18(17):3115-3124, 2000 Sep.
Outcome
of patients with metastatic breast carcinoma treated at a private
medical oncology clinic.
Anderson,
W. F.; Reeves, J. E.; Elias, A., and Berkel, H. J.. Cancer. 88(1):95-107,
2000 Jan 1.
Factors
predicting for efficacy and safety of docetaxel in a compassionate-use
cohort of 825 heavily pretreated advanced breast cancer patients.
Alexandre,
J.; Bleuzen, P.; Bonneterre, J.; Sutherland, W.; Misset, J. L.;
Guastalla, J. P.; Viens, P.; Faivre, S.; Chahine, A.; Spielman,
M.; Bensmaine, A.; Marty, M.; Mahjoubi, M., and Cvitkovic, E. Journal
of Clinical Oncology. 18(3):562-573, 2000 Feb.
The
gemcitabine/epirubicin/paclitaxel combination in advanced breast
cancer [Review].
Gennari,
A.; Donati, S.; Danesi, R.; Fogli, S.; Orlandini, C.; Del Tacca,
M., and Conte, P. F. Seminars in Oncology. 27(1 Suppl 2):14-19,
2000 Feb.
Correlation
of toxicity with pharmacokinetics of pegylated liposomal doxorubicin
(Doxil) in metastatic breast carcinoma.
Lyass,
O.; Uziely, B.; Ben-Yosef, R.; Tzemach, D.; Heshing, N. I.; Lotem,
M.; Brufman, G., and Gabizon, A. Cancer. 89(5):1037-1047, 2000 Sep
1.
Metastatic
breast cancer: clinical course, prognosis and therapy related to
the first site of metastasis.
Solomayer,
E. F.; Diel, I. J.; Meyberg, G. C.; Gollan, C., and Bastert, G.
(Reprint available from: Solomayer EF Univ Heidelberg, Dept Obstet
& Gynecol Voss Str 9 D-169115 Heidelberg Germany). Breast Cancer
Research & Treatment. 59(3):271-278, 2000 Feb.
A
retrospective study of first indicators of breast cancer recurrence.
Pivot,
X.; Asmar, L.; Hortobagyi, G. N.; Theriault, R.; Pastorini, F.,
and Buzdar, A.
(Reprint available from: Pivot X Ctr Antoine Lacassagne 33 Ave Valombrose
F-06189 Nice 2 France).
Oncology. 58(3):185-190, 2000.
Clinical
progression of breast cancer malignant behavior: What to expect
and when to expect it.
Heimann,
R. and Hellman, S. Journal of Clinical Oncology. 18(3):591-599,
2000 Feb.
Palliative
effect of chemotherapy: Objective tumor response is associated with
symptom improvement in patients with metastatic breast cancer.
Geels,
P.; Eisenhauer, E.; Bezjak, A.; Zee, B., and Day, A.. Journal
of Clinical Oncology. 18(12):2395-2405, 2000 Jun.
The
role of tumour markers in improving the accuracy of conventional
chest X-ray and liver echography in the post-operative detection
of thoracic and liver metastases from breast cancer.
Nicolini,
A.; Carpi, A.; Ferrari, P.; Anselmi, L.; Spinelli, C.; Conte, M.,
and Miccoli, P. (Reprint available from: Nicolini A Univ Pisa, Dept
Internal Med Pisa Italy).. British Journal of Cancer. 83(11):1412-1417,
2000 Dec.
Minimal
solid tumor involvement of regional and distant sites - When is
a metastasis not a metastasis?
Page,
D. L.; Anderson, T. J., and Carter, B. A. (Reprint available from:
Page DL
Vanderbilt Univ, Med Ctr, Dept Pathol C3311 Med Ctr N,1161 21st
Ave S Nashville, TN 37232 USA). Cancer. 86(12):2589-2592, 1999 Dec
15. No abstract
Radiation
therapy in the management of brain metastases from breast cancer.
Breast Cancer Research & Treatment.
Fokstuen,
T.; Wilking, N.; Rutqvist, L. E.; Wolke, J.; Liedberg, A.; Signomklao,
T., and Fernberg, J. O. (Reprint available from: Fokstuen T Karolinska
Hosp, Radiumhemmet, Dept Oncol S-17176 Stockholm Sweden).. 62(3):211-216,
2000 Aug.
Stereotactic
radiosurgery for brain metastases from breast cancer.
Firlik,
K. S.; Kondziolka, D.; Flickinger, J. C., and Lunsford, L. D. Annals
of Surgical Oncology. 7(5):333-338, 2000 Jun.
Top
of Page
|
